Skip to Main Content

Paper Details

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
2
2022
-expressing T cells, Anti-PD-1, CD3, CD4+, CD8, CD8+, CD8+ T cells, HNSCC, Head and Neck Squamous Cell Carcinoma, L1-2, LAG, LAG-3, MDSC, MDSC-like populations, PBMCs, PD, PD-, PD-1, T-cell Receptor, T-cell clones, TCR, TCR repertoire, TIM-3, circulating T-cell populations, cisplatin, expressing T-cell, human, mEERL model, mouse, patients, peripheral blood mononuclear cells

Datasets

Release 1.2